GK

Healthcare · Hospital

Gujarat Kidney & Super Speciality Ltd (GKSL)

₹149.28

Mkt cap
₹1,261 Cr
P/E ratio
66.40
P/B
4.47
Div yield
0.00%
ROE
11.10%
ROCE
14.50%
EPS (TTM)
₹2.25
Book value
₹33
52W range
98–210
Sector
Healthcare

Price history

Previous close

Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services. [1]

NSE GKSLBSE 544666
Health check
Constructive
ValuationFair
ProfitabilityAverage
GrowthHigh
TechnicalsNeutral
52-week range
−28.85% from high
₹149
₹98+51.77% from low₹210
Current
₹149.28
Prev close
₹150.55
Day
−0.84%
Price performance
1D
−1.36%
1W
−4.61%
1M
−17.25%
3M
−5.05%
6M
+6.47%
1Y
—
YTD
+45.34%

Financials

Revenue, profit & margin
P/E ratio
66.4×
GKSL is 30% above the sector median of 51.1×
GKSL66.4×
Sector median51.1×
 Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales9.4111.799.7815.2612.9323.2530.5834.2938.09
YoY Sales growth+37.41%+97.20%+212.68%+124.71%+194.59%
Expenses4.557.197.176.647.8116.3524.2825.9227.88
Operating Profit4.864.602.618.625.126.906.308.3710.21
OPM %51.65%39.02%26.69%56.49%39.60%29.68%20.60%24.41%26.80%
Other Income0.040.050.050.010.090.060.710.690.59
Interest0.160.170.160.180.280.600.820.660.66
Depreciation0.740.880.900.960.901.331.511.441.52
Profit before tax4.003.601.607.494.035.034.686.968.62
Tax %26.25%29.72%16.88%27.77%28.54%26.44%-2.99%23.56%23.55%
Net Profit2.962.531.345.402.883.704.825.326.60
EPS in Rs0.520.440.230.850.470.370.640.660.74
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +4.36% · closed higher next day 2 of last 3
 Q2FY26†Q1FY27Q2FY27
Broadcast5 Aug '2614 Aug '26◦4 Nov '26◦
Earnings day+3.08%+10.94%−0.94%
+1 day+2.60%+12.48%−2.37%
+5 days+2.00%+11.81%−2.52%
+15 days+16.69%+29.25%—
+30 days+36.21%+28.92%—
FilingPDFXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
71.45%Promoter
Promoters71.45%
FIIs6.52%1.63
DIIs0.25%0.31
Public21.77%1.33
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Apollo Hospitals₹8,712.5055.341,25,2720.23%660+30.04%7,615+23.04%17.45%
Max Healthcare₹1,030.9070.641,00,3400.19%414−15.54%2,569+20.31%14.71%
Manipal Health₹701.9598.4692,3330.00%285+10.29%3,399+37.32%12.10%
Aster DM Quality₹737.95122.7164,3250.41%322+148.12%2,829+136.32%11.57%
Fortis Health.₹806.8056.7760,9100.12%320+2.01%2,735+17.30%13.45%
Narayana Hrudaya₹1,907.6043.0838,9840.24%301+16.61%2,844+73.01%15.50%
Global Health₹1,444.2059.9838,8310.03%219+51.38%1,469+33.64%17.37%
Gujarat Kidney₹159.9066.351,2610.00%7+118.73%38+194.59%14.48%
Median: 31 Co.₹508.2051.097,2120.00%40+22.67%431+22.77%14.62%

Filings